|BBH -- USA Etf|| |
USD 128.29 0.24 0.19%
Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding VanEck Vectors Biotech ETF is 'Sell'
. Macroaxis provides VanEck Vectors buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BBH positions. The advice algorithm takes into account all of VanEck Vectors Biotech available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BBH buy-and-hold prospective. Check also VanEck Vectors Analyst Recommendation
to compare Macroaxis Buy or Sell Recommendation with current analyst consensus.
For the selected time horizon VanEck Vectors Biotech ETF has a mean deviation of 0.7972, semi deviation of 0.6983, standard deviation of 1.13, variance of 1.27, downside variance of 1.18 and semi variance of 0.4876
Macroaxis provides recommendation on VanEck Vectors Biotech to complement and cross-verify current analyst consensus
on VanEck Vectors Biotech ETF. Our buy or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. Please use VanEck Vectors Biotech One Year Return
and Net Asset
to make buy, hold, or sell decision on VanEck Vectors.
Returns Distribution Density
|Mean Return||0.19||Value At Risk||1.63|
|Potential Upside||2.00||Standard Deviation||1.13|
|Security Type||Shares||Value||Conservest Capital Advisors Inc||Fund Units||10 K||1.2 M||Susquehanna International Group Llp||Call Options||15.1 K||1.8 M|
VanEck Vectors Greeks
VanEck Vectors Volatility Alert
VanEck Vectors Biotech ETF has relatively low volatility with skewness of 0.63 and kurtosis of 1.28. However, we advise all investors to independently investigate VanEck Vectors Biotech ETF to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
VanEck Vectors Fundamental Vs Peers
|The fund generated three year return of -4.0%|
|VanEck Vectors Biotech ETF holds all of its assets under management (AUM) in equities|